Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion

Annals of Oncology

Volumn 21, Issue 3, 2009, Pages 589-596

  Wu, D ^a   Chen, L ^a   Liao, W ^a   Ding, Y ^a   Zhang, Q ^a   Li, Z ^a   Liu, L ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Fascin1; Nasopharyngeal carcinoma; Prognosis

Indexed keywords

FASCIN; FASCIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE DISRUPTION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 77949576515     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp333     Document Type: Article

References (29)

1. Ho JH. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978; 4: 182-198.
2. Hong MH, Mai HQ, Min HQ et al. A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma. Cancer 2000; 89: 242-247.
3. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12: 421-429.
4. Chang KP, Hsu CL, Chang YL et al. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Oral Oncol 2008; 44: 784-792.
5. Chin D, Boyle GM, Porceddu S et al. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006; 6: 1111-1118.
6. Segawa Y, Oda Y, Yamamoto H et al. Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma. Oncol Rep 2009; 21: 1197-1202.
7. Qian CN, Guo X, Cao B et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 2002; 62: 589-596.
8. Oudejans JJ, Harijadi H, Kummer JA et al. High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. J Pathol 2002; 198: 468-475.
9. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80: 1529-1537.
10. Kureishy N, Sapountzi V, Prag S et al. Fascins, and their roles in cell structure and function. Bioessays 2002; 24: 350-361.
11. Yamashiro S, Yamakita Y, Ono S, Matsumura F. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998; 9: 993-1006.
12. Yoder BJ, Tso E, Skacel M et al. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 2005; 11: 186-192.
13. Rodriguez-Pinilla SM, Sarrio D, Honrado E et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 2006; 12: 1533-1539.
14. Kabukcuoglu S, Oner U, Ozalp SS et al. The role of actin bundling protein fascin in the progression of ovarian neoplasms. Eur J Gynaecol Oncol 2006; 27: 171-176.
15. Jawhari AU, Buda A, Jenkins M et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003; 162: 69-80.
16. Vignjevic D, Schoumacher M, Gavert N et al. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 2007; 67: 6844-6853.
17. Zhang H, Xu L, Xiao D et al. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006; 59: 958-964.
18. Hashimoto Y, Shimada Y, Kawamura J et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004; 67: 262-270.
19. Pelosi G, Pastorino U, Pasini F et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003; 88: 537-547.
20. Swierczynski SL, Maitra A, Abraham SC et al. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 2004; 35: 357-366.
21. Tong GX, Yee H, Chiriboga L et al. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 2005; 36: 741-746.
22. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 2005; 37: 1787-1804.
23. Soumaoro LT, Uetake H, Higuchi T et al. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004; 10: 8465-8471.
24. Masunaga R, Kohno H, Dhar DK et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 2000; 6: 4064-4068.
25. Elbashir SM, Harborth J, Lendeckel W et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
26. Liu L, Zhang Q, Zhang Y et al. Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia 2006; 8: 917-924.
27. Chou J, Lin YC, Kim J et al. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck 2008; 30: 946-963.
28. Hashimoto Y, Parsons M, Adams JC. Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis. Mol Biol Cell 2007; 18: 4591-4602.
29. Li YH, Hu CF, Shao Q et al. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med 2008; 6: 1.